Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The company is seeking approval in primary and revision breast reconstruction, aiming to expand its indication following a multicenter IDE study in post-mastectomy patients.